Method development, qualification and validation are at the core of our service portfolio. From product characterization to first-in-human to later stages of your drug development/approval cycle, we can support assay development and technology transfer, as well as method qualification and validation for GMP release and long-term stability studies of your drug substances and drug products.

Frontage offers extensive experience and advanced technology in biomarker assay development, validation, and testing, adhering to CAP, CLIA, GLP, and GCLP standards.

​Frontage’s Biologics, Gene, and Cell Therapy Operations (BGC) Unit supports the development of biologics products. We develop complex analytical techniques to support drug substances, drug products, comparability studies, and stability programs.